Federal regulators ordered the embattled Emergent BioSolutions plant in Baltimore to stop producing new Johnson & Johnson vaccine material pending a completed inspection, the company said Monday. In a regulatory filing with the Securities…
Copyright © 2024 | WordPress Theme by MH Themes